Search results
Results from the WOW.Com Content Network
Montelukast, sold under the brand name Singulair among others, is a medication used in the maintenance treatment of asthma. [6] It is generally less preferred for this use than inhaled corticosteroids. [6] It is not useful for acute asthma attacks. [6] Other uses include allergic rhinitis and hives of long duration. [6]
every night at bedtime quaque hora somni q.d.s, qds, QDS 4 times a day quater die sumendum q.i.d, qid 4 times a day quater in die q.h., qh every hour, hourly quaque hora q.o.d., qod every other day / alternate days quaque altera die q.p.m., qPM, qpm every afternoon or evening: quaque post meridiem q.s., qs a sufficient quantity
at bedtime hor. intermed. horis intermediis: at intermediate hours hor. tert. horis tertiis: every third hour h.s. hora somni (at the hour of sleep) at bedtime [or] half-strength ambiguous (2 meanings, easily conflated); spell out IBW ideal body weight (for dosing based on clearance estimation) ID intradermal IJ, inj. injectio: injection
Singulair was a blockbuster product for Merck after its launch in 1998, offering relief ... The agency also convened a group of internal experts around the same time to look into why the drug ...
Montelukast indicated for the treatment of dementia, asthma and allergy, is being developed variously for uses as a film by IntelGenx and Aquestive Therapeutics (formerly known as Monosol Rx). Midatech, a company specializing in nanotechnology, is partnering with Aquestive Therapeutics to create a film-based insulin.
Kim Kardashian is staying out of ex-husband Kanye West's orbit amid his headline-making antics with Bianca Censori. “Kim has distanced herself from him which is why she hasn’t said anything ...
The effectiveness of auxiliary labels can vary greatly between different label formats and specific text, with a 2006 survey finding that one common multi-step, complex label ("Do not take dairy products, antacids, or iron preparations within 1 hour of this medication") was interpreted correctly only 7.6% of the time.
Zafirlukast is FDA-approved for the prevention and treatment of asthma in adults and children older than 5 years old. [1] Like other leukotriene receptor antagonists, zafirlukast is thought to be useful for the long-term treatment of asthma, but it is generally less effective than inhaled glucocorticoids as monotherapy (which are the standard of care) or long-acting beta-2 agonists in ...